Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Cortot

Showing results (211-220 of 224) with videos related to

Pageof 23
Sort By:
Gastroenterology|September 1, 1996
Clinical characteristics of Crohn's disease in 72 familiesJ F Colombel, B Grandbastien, C Gower-Rousseau, et al.
Revue Des Maladies Respiratoires|December 18, 2010
[Adult asthma exacerbations in questions]D Montani, A Cavailles, L Bertoletti, et al.
Respiratory Medicine and Research|June 22, 2020
Proposals for managing patients with thoracic malignancies during COVID-19 pandemicN Girard, L Greillier, G Zalcman, et al.
Gastroenterologie Clinique Et Biologique|February 15, 2002
[Infliximab therapy for Crohn's disease anoperineal lesions]A Ouraghi, S Nieuviarts, J L Mougenel, et al.
Alimentary Pharmacology & Therapeutics|August 28, 2009
The efficacy and safety of a third anti-TNF monoclonal antibody in Crohn's disease after failure of two other anti-TNF antibodiesM Allez, S Vermeire, N Mozziconacci, et al.
Mucosal Immunology|October 17, 2013
Aluminum enhances inflammation and decreases mucosal healing in experimental colitis in miceG Pineton de Chambrun, M Body-Malapel, I Frey-Wagner, et al.
Gut|February 17, 2006
European evidence based consensus on the diagnosis and management of Crohn's disease: current managementS P L Travis, E F Stange, M Lémann, et al.
European Journal of Gastroenterology & Hepatology|March 1, 1996
Placebo-controlled clinical trial of mesalazine in the prevention of early endoscopic recurrences after resection for Crohn's disease. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID)C Florent, A Cortot, P Quandale, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 25, 2015
Lung cancer patients with HER2 mutations treated with chemotherapy and HER2-targeted drugs: results from the European EUHER2 cohortJ Mazières, F Barlesi, T Filleron, et al.
Nature|February 29, 1996
Mapping of a susceptibility locus for Crohn's disease on chromosome 16J P Hugot, P Laurent-Puig, C Gower-Rousseau, et al.
Pageof 23

Showing results (211-220 of 224) with videos related to

Sort By:
Pageof 23
Gastroenterology|September 1, 1996
Clinical characteristics of Crohn's disease in 72 familiesJ F Colombel, B Grandbastien, C Gower-Rousseau, et al.
Revue Des Maladies Respiratoires|December 18, 2010
[Adult asthma exacerbations in questions]D Montani, A Cavailles, L Bertoletti, et al.
Respiratory Medicine and Research|June 22, 2020
Proposals for managing patients with thoracic malignancies during COVID-19 pandemicN Girard, L Greillier, G Zalcman, et al.
Gastroenterologie Clinique Et Biologique|February 15, 2002
[Infliximab therapy for Crohn's disease anoperineal lesions]A Ouraghi, S Nieuviarts, J L Mougenel, et al.
Alimentary Pharmacology & Therapeutics|August 28, 2009
The efficacy and safety of a third anti-TNF monoclonal antibody in Crohn's disease after failure of two other anti-TNF antibodiesM Allez, S Vermeire, N Mozziconacci, et al.
Mucosal Immunology|October 17, 2013
Aluminum enhances inflammation and decreases mucosal healing in experimental colitis in miceG Pineton de Chambrun, M Body-Malapel, I Frey-Wagner, et al.
Gut|February 17, 2006
European evidence based consensus on the diagnosis and management of Crohn's disease: current managementS P L Travis, E F Stange, M Lémann, et al.
European Journal of Gastroenterology & Hepatology|March 1, 1996
Placebo-controlled clinical trial of mesalazine in the prevention of early endoscopic recurrences after resection for Crohn's disease. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID)C Florent, A Cortot, P Quandale, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 25, 2015
Lung cancer patients with HER2 mutations treated with chemotherapy and HER2-targeted drugs: results from the European EUHER2 cohortJ Mazières, F Barlesi, T Filleron, et al.
Nature|February 29, 1996
Mapping of a susceptibility locus for Crohn's disease on chromosome 16J P Hugot, P Laurent-Puig, C Gower-Rousseau, et al.
Pageof 23